FDA approves Zepzelca for metastatic SCLC June 15, 2020 By Karen Carey No Comments Two months earlier than expected, Pharmamar SA and partner Jazz Pharmaceuticals plc received an accelerated FDA approval of Zepzelca to treat relapsed metastatic small-cell lung cancer patients.Read More